hexamethonium has been researched along with Alloxan Diabetes in 5 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osaka, T | 1 |
| Endo, M | 1 |
| Yamakawa, M | 1 |
| Inoue, S | 1 |
| Maeda, C | 1 |
| Schaan, B | 1 |
| Oliveira, E | 1 |
| Oliveira, V | 1 |
| De Angelis, K | 1 |
| Irigoyen, M | 1 |
| Minker, E | 1 |
| Kac, P | 1 |
| Blazsó, G | 1 |
| Koltai, M | 1 |
| Severson, K | 1 |
| Tackett, RL | 1 |
| Takata, Y | 1 |
| Yamashita, Y | 1 |
| Takishita, S | 1 |
| Tomita, Y | 1 |
| Tsuchihashi, T | 1 |
| Nakao, Y | 1 |
| Iwase, M | 1 |
| Sadoshima, S | 1 |
| Fujishima, M | 1 |
5 other studies available for hexamethonium and Alloxan Diabetes
| Article | Year |
|---|---|
Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system.
Topics: Adrenal Glands; Adrenalectomy; Animals; Area Postrema; Body Temperature; Brain Stem; Diabetes Mellit | 2005 |
Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arginine Vasopressin; Baroreflex; Blood Glucose; B | 2007 |
A study of the origin of altered pharmacological reactivity of synaptic structures caused by diabetes and pretreatment with contrainsular agents.
Topics: Animals; Cortisone; Diabetes Mellitus, Experimental; Female; Ganglia, Sympathetic; Hexamethonium; He | 1984 |
Enhanced hemodynamic response to [D-ALA2,D-MET5]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement.
Topics: Animals; Blood Flow Velocity; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Dose-R | 1998 |
Suppression of the renin-angiotensin system induced by streptozotocin treatment in neonatal spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Diabetes Mellitus, Experim | 1990 |